Skip to main content Skip to section navigation Skip to footer
Partnering Careers
IMV Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • DPX Delivery Platform
    • Overview
    • Scientific Materials
  • Pipeline
    • Overview
    • Maveropepimut-S
    • Expanded Access
  • News & Media
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contacts
    • FAQ
  • Contact
    • Get in Touch
    • Safety & Respect
  • CCAA Proceedings
  • Partnering
  • Careers

IR Calendar

Investors

Investors

  • Overview
  • Press Releases
  • Events, Webcasts & Presentations
    • Overview
    • IR Calendar
    • Presentations
    • Scientific Materials
    • Email Alerts
  • Financial Info
    • Financial Results
    • Tax Information
    • Proxy Information
    • Stock Option Plan
    • Deferred Share Unit Plan
  • Stock Data
    • OTC Pink: IMVIQ
    • TSX: IMV
    • Analyst Coverage
  • Filings
    • SEC Filings
    • SEDAR
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contacts
  • FAQ

  • Events, Webcasts & Presentations

  • Overview
  • IR Calendar
  • Presentations
  • Scientific Materials
  • Email Alerts

Company Webcast - Biomarkers Associated With Clinical Response in Patients With r/r DLBCL Treated With DPX-Survivac Combination Therapy and review of Q3 earnings and highlights

Nov 12, 2020 8:00 am EDT
Earnings Release
PDF HTML
MD&A
PDF
Financial Reports
PDF
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Visit us on Twitter

    Twitter
  • Visit us on LinkedIn

    LinkedIn
  • Visit us on Youtube

    Youtube
© IMV Inc. All Rights Reserved.
Privacy Policy Terms of Use Sitemap Manage Cookie Preferences